Type 2 diabetes, prevention of myocardial infarction, patient education, shared decision making Circulatory System Myocardial infarction
Conditions
Interventions
Intervention group: ISDM programme comprising (1) an evidence-based patient decision aid on the prevention of myocardial infarction, (2) a structured teaching module provided by medical assistants, (
Sponsors
European Foundation for the Study of Diabetes
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Primary care practices are eligible if they meet the following criteria: 1. Employ at least one diabetes educator or a medical assistant or a nurse with further training in structured diabetes education 2. Provide structured teaching and treatment within the Disease Management Programme for patients with type 2 diabetes Patients are eligible if they meet the following criteria: 1. Age between 40 and 69 2. Type 2 diabetes 3. HbA1c-value less than 9% 4. Previous participation in structured treatment and teaching sessions as they are typically provided within the Disease Menagement Programme
Exclusion criteria
Exclusion criteria: 1. Previous diagnosis of ischaemic heart disease (ICD I20-I25), 2. Stroke (ICD I63) 3. Proliferative retinopathy 4. Chronic kidney disease stage 3 or higher 5. Metastatic cancer 6. Addicted to alcohol 7. Cared by a legal guardian
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure is defined as the adherence to blood pressure drug treatment or if not applicable the adherence to statin treatment. This primary outcome measure is operationalised as adherence to drug prescriptions at six months follow-up. Telephone interviews will be conducted to assess the adherence to the current drug prescriptions. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Informed choice regarding statin treatment, blood pressure control, glucose control, and smoking cessation 2. The achievement of treatment goals regarding statin treatment, blood pressure, HbA1c, and smoking cessation 3. Prioritisation of treatment goals 4. Realistic expectations on the individual heart attack risk and on probabilities of benefits and harms of the available treatment options 5. The level of patient knowledge and understanding relating to the concept of risk, the notion of heart attack risk, and the benefits and harms of preventive treatment | — |
Countries
Germany
Outcome results
None listed